Find Investable Startups and Competitors
Search thousands of startups using natural language—just describe what you're looking for
Top 50 Ai Diagnostics
Discover the top 50 Ai Diagnostics startups. Browse funding data, key metrics, and company insights. Average funding: $6.8M.
Showing 6 startups matching the selected criteria.
Sort by
ADOR develops a point-of-care molecular diagnostics platform utilizing multiplex syndromic panels for the rapid identification of infectious diseases and antibiotic resistance. The system delivers results in 30-45 minutes, enabling immediate clinical decision-making in response to emerging pathogens.
Funding: $17.5M
Rough estimate of the amount of funding raised
BATM Ltd
BATM Ltd
Funding: $17.5M
Rough estimate of the amount of funding raised
SG Diagnostics manufactures point-of-care diagnostic tests, including COVID-19 antigen rapid test kits and HbA1c analysis systems, to provide accurate and accessible medical testing solutions. Their products enable early detection of infectious diseases and chronic conditions, facilitating timely medical intervention in various healthcare settings.
AI Diagnostics provides an AI-powered platform that analyzes lung sounds using a digital stethoscope to improve tuberculosis screening accuracy. Its proprietary AI model identifies acoustic patterns indicative of pulmonary TB, offering a rapid and cost-effective screening solution that reduces missed diagnoses and unnecessary testing.
Funding: $22.7K
Rough estimate of the amount of funding raised
Innov4Good
Innov4Good
Funding: $22.7K
Rough estimate of the amount of funding raised
In Diagnostics has developed a disposable lab-quality spectrophotometer that analyzes a single drop of blood to measure kidney function and liver enzymes, providing results with over 95% correlation to traditional lab tests. This technology enables rapid, instrument-free blood testing in any setting, addressing the need for accessible and efficient health monitoring.
Funding: $3.0M
Rough estimate of the amount of funding raised
Funding: $3.0M
Rough estimate of the amount of funding raised
This company manufactures raw materials for rapid diagnostic tests and dietary supplements. They offer self-monitoring kits for lifestyle diseases, including a predictive self-diagnostic kit for heart attack, making healthcare monitoring accessible and affordable.
AGED Diagnostics develops a blood test utilizing targeted genomic sequencing to diagnose and stage liver disease, including NASH and fibrosis. This noninvasive assessment measures circulating genetic biomarkers to differentiate disease severity from benign conditions. The technology aims to enable earlier patient intervention, improving outcomes and reducing healthcare costs associated with late-stage liver disease.